178 related articles for article (PubMed ID: 31478565)
1. Exploration of the structure-activity relationship and druggability of novel oxazolidinone-based compounds as Gram-negative antibacterial agents.
Ding S; Ji JC; Zhang MJ; Yang YS; Wang R; Zhu XL; Wang LH; Zhong Y; Gao L; Lu M; Liu J; Chen Y
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900129. PubMed ID: 31478565
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents.
Ding S; Dai RY; Wang WK; Cao Q; Lan LF; Zhou XL; Yang YS
Bioorg Med Chem Lett; 2018 Jan; 28(2):94-102. PubMed ID: 29233653
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of 5-substituted oxazolidinones.
Phillips OA; Udo EE; Ali AA; Al-Hassawi N
Bioorg Med Chem; 2003 Jan; 11(1):35-41. PubMed ID: 12467705
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity studies of novel benzocycloheptanone oxazolidinone antibacterial agents.
Vara Prasad JV; Boyer FE; Chupak L; Dermyer M; Ding Q; Gavardinas K; Hagen SE; Huband MD; Jiao W; Kaneko T; Maiti SN; Melnick M; Romero K; Patterson M; Wu X
Bioorg Med Chem Lett; 2006 Oct; 16(20):5392-7. PubMed ID: 16901693
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel oxazolidinone antimicrobial agents.
Ebner DC; Culhane JC; Winkelman TN; Haustein MD; Ditty JL; Ippoliti JT
Bioorg Med Chem; 2008 Mar; 16(5):2651-6. PubMed ID: 18077175
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
7. Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity.
Spaulding A; Takrouri K; Mahalingam P; Cleary DC; Cooper HD; Zucchi P; Tear W; Koleva B; Beuning PJ; Hirsch EB; Aggen JB
Bioorg Med Chem Lett; 2017 Dec; 27(23):5310-5321. PubMed ID: 29102393
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship studies of novel [6,6,5] tricyclic oxazolidinone derivatives as potential antibacterial agents.
Xue T; Ding S; Guo B; Chu W; Wang H; Yang Y
Bioorg Med Chem Lett; 2015; 25(10):2203-10. PubMed ID: 25838143
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids.
Selvakumar N; Kumar GS; Azhagan AM; Rajulu GG; Sharma S; Kumar MS; Das J; Iqbal J; Trehan S
Eur J Med Chem; 2007 Apr; 42(4):538-43. PubMed ID: 17150281
[TBL] [Abstract][Full Text] [Related]
10. Current Landscape and Future Perspective of Oxazolidinone Scaffolds Containing Antibacterial Drugs.
Zhao Q; Xin L; Liu Y; Liang C; Li J; Jian Y; Li H; Shi Z; Liu H; Cao W
J Med Chem; 2021 Aug; 64(15):10557-10580. PubMed ID: 34260235
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
Hubschwerlen C; Specklin JL; Baeschlin DK; Borer Y; Haefeli S; Sigwalt C; Schroeder S; Locher HH
Bioorg Med Chem Lett; 2003 Dec; 13(23):4229-33. PubMed ID: 14623007
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials.
Johnson PD; Aristoff PA; Zurenko GE; Schaadt RD; Yagi BH; Ford CW; Hamel JC; Stapert D; Moerman JK
Bioorg Med Chem Lett; 2003 Dec; 13(23):4197-200. PubMed ID: 14623000
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials.
Komine T; Kojima A; Asahina Y; Saito T; Takano H; Shibue T; Fukuda Y
J Med Chem; 2008 Oct; 51(20):6558-62. PubMed ID: 18826297
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.
Ang W; Ye W; Sang Z; Liu Y; Yang T; Deng Y; Luo Y; Wei Y
Bioorg Med Chem Lett; 2014 Mar; 24(6):1496-501. PubMed ID: 24582981
[TBL] [Abstract][Full Text] [Related]
15. Effects of varied substituents on the antibacterial activity of triazolylmethyl oxazolidinones.
Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
Arch Pharm (Weinheim); 2012 Oct; 345(10):790-803. PubMed ID: 22886578
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Meng QG; Wang Q; Liu J
Yao Xue Xue Bao; 2003 Oct; 38(10):754-9. PubMed ID: 14730898
[TBL] [Abstract][Full Text] [Related]
17. [Modification of novel oxazolidinone derivatives at C-5 side chain and their antibacterial activities].
Zhai X; Zhang GG; Gou DH; Liu JP; Gong P
Yao Xue Xue Bao; 2006 Oct; 41(10):985-9. PubMed ID: 17184118
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids.
Hubschwerlen C; Specklin JL; Sigwalt C; Schroeder S; Locher HH
Bioorg Med Chem; 2003 May; 11(10):2313-9. PubMed ID: 12713843
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)}-phenyl] -ethyl]-piperazin-1-yl}-fluoroquinolones].
Yu HJ; Zhou WC
Yao Xue Xue Bao; 2006 Oct; 41(10):990-9. PubMed ID: 17184119
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents.
Khera MK; Cliffe IA; Mathur T; Prakash O
Bioorg Med Chem Lett; 2011 May; 21(10):2887-9. PubMed ID: 21507643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
